Reagent | H-FABP (Cardiac)
A Superior Marker of Acute Coronary Syndrome
Benefits of the Randox H-FABP (Cardiac) Assay
The Randox latex enhanced immunoturbidimetric (L.E.I) method offers a more convenient, high performing and time efficient (results in 14 minutes, depending on analyser) method compared to traditional ELISA testing.
A correlation coefficient of r=0.97 was displayed when the Randox methodology was compared against commercially available methods.
Wide measuring range
The Randox H-FABP assay can comfortably detect levels outside of the healthy range, measuring between 0.747 – 120ng/ml.
Liquid ready-to-use assay
The Randox H-FABP assay is available in a liquid ready-to-use format for convenience and ease-of-use.
Dedicated calibrator and controls available
Dedicated H-FABP calibrator and controls available offering a complete testing package.
Applications available detailing instrument-specific settings for the convenient use of the Randox H-FABP assay on a variety of clinical chemistry analysers.
Reagents Resource Hub
 Release of fatty acid-binding protein from isolated rat heart subjected to ischemia and reperfusion or to the calcium paradox. Glatz, J F, et al. 52, Maastricht : The Clinical Biochemist, 1988, Vol. 148.
 Clinical study of H-FABP for risk stratification and prognosis in patients with early cTnT-negative ACS. Liu, Yawei, et al. Beijing : Internal Journal of Clinical and Experimental Medicine, 2017. 1940-5901.
 Al-Dabbagh, Ihsan Hassan. Heart type fatty acid binding protein H-FABP. College of Medicine-Mosul. [Online] [Cited: November 06, 2018.] http://medicinemosul.uomosul.edu.iq/files/news/news_4087987.pdf.
 Supplementary Online Content: Serial Changes in Highly Sensitive Troponin I Assay and Early Diagnosis of Myocardial Infarction. Keller, T, Zeller, Tanja and Ojeda, Francisco. Hamburg : JAMA, 2011.
 Clinical and analytical evaluation of an immunoturbidimetric heart-type fatty acid-binding protein assay. Carless, Daniel R, et al. 1, s.l. : Scandinavian Journal of Clinical and Laboratory Investigation, 2013, Vol. 73.
 Misdiagnosis of Myocardial Infarction Related to Limitations of the Current Regulatory Approach to Define Clinical Decision Values for Cardiac Troponin. Wildi, Karin, et al. Trimbach : Circulation, 2015.
 Heart Fatty Acid Binding Protein and cardiac troponin: development of an optimal rule-out strategy for acute myocardial infarction. Young, Joanna M, et al. Christchurch : BMC Emergency Medicine, 2016.
 Diagnostic Performance of a Combination Biomarker Algorithm for Rule-Out of Acute Myocardial Infarction at Time of Presentation to the Emergency Department, Using Heart-Type Fatty Acid-Binding Protein and High-Sensitivity Troponin T tests. Navarro, César O, et al. Belfast : Journal of Clinical and Experimental Cardiology, 2018.
 Heart-Type Fatty Acid-Binding Protein Predicts Long-Term Mortality and Re-Infarction in Consecutive Patients With Suspected Acute Coronary Syndrome Who Are Troponin-Negative. Viswanathan, Karthik, et al. 23, Leeds : Journal of the American College of Cardiology, 2010, Vol. 55. 0735-1097.
 Heart-type fatty acid-binding protein (H-FABP) and highly sensitive troponin T (hsTnT) as markers of myocardial injury and cardiovascular events in elective percutaneous coronary intervention (PCI). Connolly, M, et al. 1, Belfast : QJM: An International Journal of Medicine, 2017, Vol. 111.